Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;41(4):334-9.

miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma

Gholamhossein Tamaddon  1 , Bita Geramizadeh  2 , Mohammad Hossein Karimi  3 , Seyed Javad Mowla  4 , Said Abroun  1
Affiliations

miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma

Gholamhossein Tamaddon et al. Iran J Med Sci. 2016 Jul.

Abstract

Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma. MicroRNAs (miRNAs) are endogenous small RNA, which can regulate gene expression at the post-transcriptional level. MiRNA profiling has shown a great potential as novel diagnostic and prognostic biomarkers. The present study was performed at the Nemazee Teaching Hospital (Shiraz, Iran) from 2011 to 2013. The aim of this study was to assess the deregulation of miRNAs profiles in DLBL against hyperplasic reactive lymph node as a normal. This could serve as a biomarker for DLBL. The miRCURY LNA™ microarray was used on the total RNA, which was extracted from formalin-fixed paraffin-embedded tissue of 24 de novo diffuse large B-cell lymphoma patients and 14 normal lymph nodes. The greatest changes were detected in miR-4284 and miR-4484 level in patient's lymphoma samples. These miRNAs can act as a diagnostic biomarker for DLBL.

Keywords: Diffuse; Large B-Cell; Lymphoma; MicroRNAs; Microarray Analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
M/A plot show normalization by the use of spike-ins and LOWESS. Green: Hy3 controls; Red: Spike-ins; Black: All other probes.
Figure 2
Figure 2
The principal component analysis performed on all samples and on the top 50 microRNAs of DLBL and normal.
Figure 3
Figure 3
Heat map and unsupervised hierarchical clustering show miRNAs micro array of DLBL against normal samples. Red color display an expression below the reference channel and green color display the expression higher than the reference channel.
Figure 4
Figure 4
The most alteration shows microRNAs expressions of DLBL patients against normal.
See this image and copyright information in PMC

References

    1. Macfarlane LA, Murphy PR. MicroRNA:Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537–61. doi: 10.2174/138920210793175895. [ PMC Free Article] - DOI - PMC - PubMed
    1. Pillai RS. MicroRNA function:multiple mechanisms for a tiny RNA? RNA. 2005;11:1753–61. doi: 10.1261/rna.2248605. [ PMC Free Article] - DOI - PMC - PubMed
    1. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66. doi: 10.1038/nrc1997. - DOI - PubMed
    1. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82. doi: 10.1182/blood-2003-05-1545. - DOI - PubMed
    1. Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet. 2008;181:8–15. doi: 10.1016/j.cancergencyto.2007.10.008. [ PMC Free Article] - DOI - PMC - PubMed

LinkOut - more resources